Combined Shareholders’ Meeting of 27 May 2021

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

Documents-availability-2021-Ipsen-Combined-Shareholders-Meeting.pdf
Convening-notice-to-the-Meeting-published-at-the-BALO-on-7-May-2021-Translation-for-information.pdf
Voting-form-2021-Ipsen-Combined-Shareholders-Meeting-2.pdf
Ipsen-voting-rights-on-19-April-2021.pdf
Auditors-report-on-the-resolutions-submitted-to-the-2021-Shareholders-Meeting.pdf
Convening-notice-2021-Ipsen-Combined-Shareholders-Meeting-2.pdf

Understanding the true impact of living with FOP

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023